| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/26/2011 | US20110123499 Cellular differentiation promotion |
| 05/26/2011 | US20110123497 Graft composition for neural tissue regeneration, method of production and uses thereof |
| 05/26/2011 | US20110123492 Immunity-inducing agent |
| 05/26/2011 | US20110123490 Heterocyclic antiviral compounds |
| 05/26/2011 | US20110123489 Heterocyclic antiviral compounds |
| 05/26/2011 | US20110123488 Method of Treatment for Cancers Associated with Elevated HER2 Levels |
| 05/26/2011 | US20110123487 Therapeutic agents comprising elastic peptides |
| 05/26/2011 | US20110123486 Methods of treating multiple myeloma and resistant cancers |
| 05/26/2011 | US20110123484 Methods and compositions for treating fus1 related disorders |
| 05/26/2011 | US20110123480 Chimeric proteins and uses thereof |
| 05/26/2011 | US20110123479 Medical adhesives for stopping heavy bleeding and sealing leakages |
| 05/26/2011 | US20110123447 Method of providing human tumor-specific antibodies |
| 05/26/2011 | CA2781598A1 Herbicide tolerant soybean plants and methods for identifying same |
| 05/26/2011 | CA2781373A1 Graft composition for neural tissue regeneration, method of production and uses thereof |
| 05/26/2011 | CA2781332A1 System for increasing gene expression and vector comprising the system |
| 05/26/2011 | CA2781248A1 Monoclonal antibodies and diagnostic uses thereof |
| 05/26/2011 | CA2781194A1 Reducing inflammation using cell therapy |
| 05/26/2011 | CA2781149A1 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| 05/26/2011 | CA2780707A1 Plants with increased yield |
| 05/26/2011 | CA2780448A1 Transgenic maize event mon 87427 and the relative development scale |
| 05/26/2011 | CA2775970A1 Methods of inducing tissue regeneration |
| 05/25/2011 | EP2325320A1 Directed complementation |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325316A1 Novel hemopoietin receptor protein, nr10 |
| 05/25/2011 | EP2325310A1 Method for obtaining purkinje progenitor cell by using neph3(65b13) and e-cadherin |
| 05/25/2011 | EP2325303A2 Thermostable reverse transcriptases and uses thereof |
| 05/25/2011 | EP2325300A1 Desaturase genes and uses thereof |
| 05/25/2011 | EP2325299A2 Methods for generating high titer helper-free preparations of recombinant AAV vectors |
| 05/25/2011 | EP2325297A2 Procedure for the undifferentiated or myeloid lineage biased expansion of haematopoietic stem cells from umbilical cord blood, mobilized peripheral blood or bone marrow |
| 05/25/2011 | EP2325296A1 Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content |
| 05/25/2011 | EP2325210A1 Monoclonal antibodies against Claudin-18 for treatment of cancer |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2325202A1 Uses of interferons with altered spatial structure |
| 05/25/2011 | EP2325201A1 Use of il-6-type Cytokines for maturation of Oocytes |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2324856A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 05/25/2011 | EP2324849A2 Selective immune down regulation (SIDR) mediated transplantation processes |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324704A2 Method and apparatus for substantially isolating plant tissues |
| 05/25/2011 | EP2324703A1 Method for improving water use efficiency in plants |
| 05/25/2011 | EP2324359A1 Monoclonal antibody stro-4 |
| 05/25/2011 | EP2324121A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 05/25/2011 | EP2324111A2 Peripheral zone tumor cells, methods for their preparation and use |
| 05/25/2011 | EP2324110A2 Elimination of a contaminating non-human sialic acid by metabolic competition |
| 05/25/2011 | EP2324109A1 Expansion of haemopoietic precursors |
| 05/25/2011 | EP2324065A1 A heparan sulphate which binds bmp2 |
| 05/25/2011 | EP2323475A1 High fructan cereal plants |
| 05/25/2011 | EP2003969B1 Mature dendritic cell compositions and methods for culturing same |
| 05/25/2011 | EP1855733B1 Microencapsulated compositions for endoluminal tissue engineering |
| 05/25/2011 | EP1664118B1 Tlr2 antagonistic antibody and use thereof |
| 05/25/2011 | EP1629095B1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 05/25/2011 | EP1499731B1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 05/25/2011 | EP1412505B1 Dna sequences for regulating transcription |
| 05/25/2011 | EP1390548B1 Cells for detection of enteroviruses |
| 05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 05/25/2011 | EP1357922B1 Cell suspension preparation technique and use |
| 05/25/2011 | EP1345959B1 Membrane scaffold proteins |
| 05/25/2011 | EP1325112B1 Methods of isolating bipotent hepatic progenitor cells |
| 05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 05/25/2011 | EP0959896B1 Method of producing secreted truncated variants of human thyrotropin receptor |
| 05/25/2011 | EP0948610B1 Subtilase variants and compositions |
| 05/25/2011 | CN1531594B Novel glyphosate N-acetyltransferase (GAT) genes |
| 05/25/2011 | CN102076865A Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| 05/25/2011 | CN102076855A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 05/25/2011 | CN102076845A Compositions for treating an arthritic condition |
| 05/25/2011 | CN102076844A Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 05/25/2011 | CN102076841A Method for distinguishing and sorting cells and device therefor |
| 05/25/2011 | CN102076359A Vaccine compositions and methods |
| 05/25/2011 | CN102076351A Pharmaceutical agent for promoting functional regeneration of damaged tissue |
| 05/25/2011 | CN102076350A Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 05/25/2011 | CN102076343A 6-substituted estradiol derivatives and methods of use |
| 05/25/2011 | CN102071205A Specific antigen of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102071203A Induced promoter |
| 05/25/2011 | CN102071196A SiRNA for inhibiting canine p53 gene expression and canine cell model of p53 gene silence |
| 05/25/2011 | CN102071193A Promoter from Brassica napus and applications thereof |
| 05/25/2011 | CN102071170A Monoclonal antibody capable of resisting heavy metal copper and preparation method thereof |
| 05/25/2011 | CN102071169A Hybridoma of DON (Deoxynivalenol) monoclonal antibody as well as preparation method and application thereof |
| 05/25/2011 | CN102071168A High metastasis human breast carcinoma cell subline and establishing method thereof |
| 05/25/2011 | CN102071167A Method and device for culturing cells such as stem cells and the like for therapy in mobile carrier mode |
| 05/25/2011 | CN102071166A Method for tissue artificial culture of hymeniacidon perleve by using program for temperature regulation and control |
| 05/25/2011 | CN102071139A Microfluidic chip-based cell three-dimensional co-culture method |
| 05/25/2011 | CN102071137A Device and method for preparing stem cells through continuous perfusion bioreactor/tank (bag) system |
| 05/25/2011 | CN102070717A Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 05/25/2011 | CN102070715A Human antibodies that bind human TNF alpha |
| 05/25/2011 | CN102070710A Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102070709A Plant transcription factor WRKY protein and coding genes and application thereof |
| 05/25/2011 | CN102070708A Protein BnL1L related to seed fatty acid synthesis as well as encoding gene and applications thereof |
| 05/25/2011 | CN102070707A Protein BnLEC1 related to seed fatty acid synthesis as well as encoding gene and applications thereof |
| 05/25/2011 | CN102070706A Protein AtL1L related to seed fatty acid synthesis as well as encoding gene and applications thereof |
| 05/25/2011 | CN102070705A Plant stress tolerance-relevant protein TaFbox2, coding gene and application thereof |
| 05/25/2011 | CN102067828A Highly metastatic model of human melanoma, cell subline, creation methods, and dynamic detection of metastasis |
| 05/25/2011 | CN101451126B Uridine diphosphate-4-one-6-deoxyglucose heterogeneous reductase and coding gene thereof and application |
| 05/25/2011 | CN101248759B Artificial enlarge method (of) Rhodobryum giganteum gametophyte |
| 05/25/2011 | CN101130763B Rapid breeding method for gingkgo callus or suspending cell |
| 05/25/2011 | CN101056973B Method of selecting myocardial cells by using intracellular mitochondria as indication |
| 05/25/2011 | CA2754954A1 High yielding soybean variety xb29z11 |
| 05/25/2011 | CA2754947A1 High yielding soybean variety xb31b11 |
| 05/25/2011 | CA2754751A1 High yielding soybean variety xb26e11 |
| 05/25/2011 | CA2754745A1 High yielding soybean variety xr27f11 |